Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential.
Saved in:
| Title: | Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential. |
|---|---|
| Authors: | Colwill M; Department of Gastroenterology, St George's University Hospital NHS Foundation Trust, London, United Kingdom.; Institute for Infection and Immunity, City St George's University Medical School, London, United Kingdom., Povlsen S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Pollok R; Institute for Infection and Immunity, City St George's University Medical School, London, United Kingdom., Patel K; Department of Gastroenterology, St George's University Hospital NHS Foundation Trust, London, United Kingdom., Goodhand J; Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom., Ahmad T; Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom., Honap S; Department of Gastroenterology, St George's University Hospital NHS Foundation Trust, London, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom. |
| Source: | Journal of Crohn's & colitis [J Crohns Colitis] 2025 Sep 28; Vol. 19 (9). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
